Austin Speier, chief strategy officer at Click Therapeutics, discusses the company’s expanded partnership with Boehringer Ingelheim.
Austin Speier, chief strategy officer at Click Therapeutics, discusses the company’s expanded partnership with Boehringer Ingelheim.